AstraZeneca is pleased with the jury’s verdict. The Company has always maintained that the plaintiffs’ allegations were without merit.
All parties have appellate rights.
Two cases making similar allegations were filed by numerous purchasers in the state court in Pennsylvania and are still pending.
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.